» Authors » Tony Teav

Tony Teav

Explore the profile of Tony Teav including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 815
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Heim S, Teav T, Cortesi F, Gallart-Ayala H, Ivanisevic J, Salamin N
Sci Rep . 2025 Jan; 15(1):2048. PMID: 39814757
The clownfish - sea anemone system is a great example of symbiotic mutualism where host «toxicity» does not impact its symbiont partner, although the underlying protection mechanism remains unclear. The...
2.
Prechtl L, Carrard J, Gallart-Ayala H, Borreggine R, Teav T, Konigstein K, et al.
Sci Rep . 2024 Oct; 14(1):25848. PMID: 39468229
Coronary artery disease (CAD) remains a leading cause of death worldwide and imposes a substantial socioeconomic burden on healthcare. Improving risk stratification in clinical practice could help to combat this...
3.
Carrard J, Hofer M, Prechtl L, Fleischlin E, Huber M, Gallart-Ayala H, et al.
PLoS One . 2024 May; 19(5):e0302477. PMID: 38717997
Introduction: Evidence indicates that sphingolipid accumulation drives complex molecular alterations promoting cardiometabolic diseases. Clinically, it was shown that sphingolipids predict cardiometabolic risk independently of and beyond traditional biomarkers such as...
4.
Medina J, Borreggine R, Teav T, Gao L, Ji S, Carrard J, et al.
Anal Chem . 2023 Jan; 95(6):3168-3179. PMID: 36716250
Lipid analysis at the molecular species level represents a valuable opportunity for clinical applications due to the essential roles that lipids play in metabolic health. However, a comprehensive and high-throughput...
5.
Strefeler A, Jan M, Quadroni M, Teav T, Rosenberg N, Chatton J, et al.
Alzheimers Res Ther . 2023 Jan; 15(1):8. PMID: 36624525
Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized by altered cellular metabolism in the brain. Several of these alterations have been found to be exacerbated in...
6.
Gander J, Carrard J, Gallart-Ayala H, Borreggine R, Teav T, Infanger D, et al.
Front Cardiovasc Med . 2022 Jan; 8:792350. PMID: 34977199
Coronary artery disease (CAD) remains the leading cause of death worldwide. Expanding patients' metabolic phenotyping beyond clinical chemistry investigations could lead to earlier recognition of disease onset and better prevention...
7.
Tran C, Turolla L, Ballhausen D, Cornaz Buros S, Teav T, Gallart-Ayala H, et al.
Mol Genet Metab Rep . 2021 Jul; 28:100777. PMID: 34258226
Background: In NANS deficiency, biallelic mutations in the -acetylneuraminic acid synthase () gene impair the endogenous synthesis of sialic acid (-acetylneuraminic acid) leading to accumulation of the precursor, -acetyl mannosamine...
8.
Carrard J, Gallart-Ayala H, Infanger D, Teav T, Wagner J, Knaier R, et al.
Metabolites . 2021 May; 11(5). PMID: 33946321
As ageing is a major risk factor for the development of non-communicable diseases, extending healthspan has become a medical and societal necessity. Precise lipid phenotyping that captures metabolic individuality could...
9.
van der Velpen V, Rosenberg N, Maillard V, Teav T, Chatton J, Gallart-Ayala H, et al.
J Neurochem . 2021 Apr; 159(2):378-388. PMID: 33829502
Levels of nicotinamide adenine dinucleotide (NAD+) are known to decline with age and have been associated with impaired mitochondrial function leading to neurodegeneration, a key facet of Alzheimer's disease (AD)....
10.
Medina J, van der Velpen V, Teav T, Guitton Y, Gallart-Ayala H, Ivanisevic J
Metabolites . 2020 Dec; 10(12). PMID: 33276464
Expanding metabolome coverage to include complex lipids and polar metabolites is essential in the generation of well-founded hypotheses in biological assays. Traditionally, lipid extraction is performed by liquid-liquid extraction using...